Loading
Latest filing published 20 Nov 2018 for Actinium Pharmaceuticals, Inc., €3,942. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
One trade, one date: on 20 November 2018, Dale L. Ludwig disclosed an open-market purchase of €3,942 in Actinium Pharmaceuticals, Inc. No broader history exists yet. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration